Michael R. Liebowitz
Department of Psychiatry
Columbia University
New York
New York 10128
USA
Name/email consistency: high
- Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial. Liebowitz, M., Lam, R.W., Lepola, U., Datto, C., Sweitzer, D., Eriksson, H. Depress. Anxiety (2010)
- A double-blind, placebo-controlled, parallel-group, flexible-dose study of venlafaxine extended release capsules in adult outpatients with panic disorder. Liebowitz, M.R., Asnis, G., Mangano, R., Tzanis, E. J. Clin. Psychiatry (2009)
- Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder. Liebowitz, M.R., Manley, A.L., Padmanabhan, S.K., Ganguly, R., Tummala, R., Tourian, K.A. Curr. Med. Res. Opin (2008)
- A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in adult outpatients with major depressive disorder. Liebowitz, M.R., Yeung, P.P., Entsuah, R. J. Clin. Psychiatry (2007)
- Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder. Liebowitz, M.R., Gelenberg, A.J., Munjack, D. Arch. Gen. Psychiatry (2005)
- A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder. Liebowitz, M.R., Mangano, R.M., Bradwejn, J., Asnis, G. J. Clin. Psychiatry (2005)